Last Price
0.307
Today's Change
+0.019 (6.59%)
Day's Change
0.284 - 0.323
Trading Volume
817,424
Market Cap
15 Million
Shares Outstanding
51 Million
Avg Volume
11,364,596
Avg Price (50 Days)
0.35
Avg Price (200 Days)
1.25
PE Ratio
-0.04
EPS
-8.31
Earnings Announcement
12-Mar-2025
Previous Close
0.29
Open
0.31
Day's Range
0.2839 - 0.3231
Year Range
0.22 - 2.63
Trading Volume
818,895
1 Day Change
6.74%
5 Day Change
9.71%
1 Month Change
-27.24%
3 Month Change
-63.21%
6 Month Change
-82.14%
Ytd Change
-16.75%
1 Year Change
-81.27%
3 Year Change
-99.33%
5 Year Change
-99.64%
10 Year Change
-99.97%
Max Change
-100.00%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.